ESTEVE Acquires HRA Pharma Rare Diseases
ESTEVE acquired HRA Pharma Rare Diseases for $297.9M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- ESTEVE
- Acquired Company
- HRA Pharma Rare Diseases
- Price
- $297.9M
- Acquisition Type
- Acquisition
- Announced
- July 10, 2024
Canonical: https://fsome.com/acquisitions/esteve-acquires-hra-pharma-rare-diseases-8109432 · For the full deal terms, timeline, and press references, please enable JavaScript.